![logo](/logos/TARO.webp)
Taro Pharmaceutical Industries Ltd.
NYSE:TARO
42.97 (USD) • At close June 21, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Taro Pharmaceutical Industries Ltd. |
Symbool | TARO |
Munteenheid | USD |
Prijs | 42.975 |
Beurswaarde | 1,615,198,185 |
Dividendpercentage | 0% |
52-weken bereik | 32.67 - 45.76 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Uday V. Baldota |
Website | https://www.taro.com |
An error occurred while fetching data.
Over Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)